Launch of adalimumab biosimilar Amjevita postponedSeptember 29, 2017Rheumatoid ArthritisAnkylosing spondylitisSpondyloarthropathiesPsoriatic Arthritis
Swedish study finds low risk of developing psoriasis in bariatric surgery patientsSeptember 29, 2017Psoriatic Arthritis
Ultrasound’s value for arthralgia may be to rule out IASeptember 20, 2017Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisPain
Adjuvant-boosted shingles vaccine earns FDA panel’s unanimous nodSeptember 13, 2017PainRheumatoid ArthritisSpondyloarthropathiesLupus & Connective Tissue DiseasesPsoriatic Arthritis
New recommendations tout biosimilars for rheumatologic diseasesSeptember 7, 2017SpondyloarthropathiesRheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitis
FDA approves second adalimumab biosimilar for multiple conditionsAugust 28, 2017Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPediatricsPsoriatic Arthritis
Noninvasive NASH test could help monitor hepatotoxicity in patients on methotrexateAugust 24, 2017Psoriatic Arthritis
Musculoskeletal ultrasound training now offered in nearly all U.S. rheumatology fellowshipsAugust 23, 2017Rheumatoid ArthritisPsoriatic ArthritisPediatricsGout
Psoriasis, psoriatic arthritis research makes headway at GRAPPA meetingAugust 10, 2017Psoriatic Arthritis
Study finds secukinumab effective for moderate to severe scalp psoriasisAugust 9, 2017Psoriatic Arthritis
First interchangeability study for an adalimumab biosimilar has begunJuly 31, 2017Psoriatic ArthritisRheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitis